Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta-blocker use in patients undergoing transcatheter aortic valve replacement
2024-518731-11-00Phase 4Authorised
- Sponsor
- University Hospital Basel
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 4 trial of carvedilol in aortic stenosis (AS), sponsored by University Hospital Basel. Primary endpoint: Primary composite endpoint at 30 days. Planned start Aug 2025; status: authorised.
02
Drugs
carvedilol
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on 2024-518731-11-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518731-11-00.